A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM) von Schvartsman, Gustavo, Glitza, Isabella Claudia, Milton, Denai, Amaria, Rodabe Navroze, Hwu, Patrick, Hwu, Wen-Jen, Diab, Adi, Wong, Michael K.K., Patel, Sapna Pradyuman, Wefel, Jeffrey Scott, Burton, Elizabeth M., Brown, Courtney, Woodman, Scott Eric, Beosch, Ingrid M., Chung, Caroline, Davies, Michael A., Tawbi, Hussein Abdul-Hassan

Volltext